A large cohort of patients around the world diagnosed with myelofibrosis (aka bone marrow cancer) will soon be able to…
For patients given less than five years to live after being diagnosed with myelofibrosis, there is a new flicker of…
How does a company with a lead asset cancer drug also get into dermatology? What does blood cancer and keloid…
When the University of Rochester came knocking on the door of biopharmaceutical company Pharmaxis (ASX: PXS), it was a boost…